transforming growth factor beta 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| cell morphogenesis |
|
|
| skeletal system development |
|
|
| cartilage condensation |
|
|
| eye development |
|
|
| response to hypoxia |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| amyloid-beta binding |
|
|
| signaling receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
|
| type II transforming growth factor beta receptor binding |
|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0070233 | Loeys-Dietz syndrome 4 | |
| DOID:5637 | pancreatic adenosquamous carcinoma | |
| DOID:9256 | colorectal cancer |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026